Clinical trials
Infarction clinical trials
Below are recruiting infarction clinical trials, each written for real people, not researchers. We’re tracking 395 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07492537Recruiting
Helping with low mood after your first heart attack
This trial is for people who have just had their first heart attack and may be feeling some low mood or sadness. It aims to understand and help with these feelings early on, before they become a bigger problem.
Roma, ItaliaAges 18 years+ - NCT07511257RecruitingPhase 4
Blood thinners after heart attack with widened arteries
This trial tests two different blood-thinner strategies for people who have had a recent heart attack and also have a widened artery (ectasia) in the heart. The goal is to find the safest and most effective way to prevent another heart attack or clot.
Mexico City, TlalpanAges 18–80 - NCT07517523Recruiting
Heart Rhythm Problems During Heart Attack
This study looks at dangerous heart rhythms that happen during a heart attack. Researchers will review medical records from 2012–2024 to understand these rhythms better and potentially improve treatment.
CaenAges 18 years+ - NCT07536802RecruitingPhase 4
Adenosine Safety and Benefit in Emergency Heart Attack Treatment
This study tests whether giving a medication called adenosine before emergency heart catheterization (a tube procedure to open blocked arteries) helps patients having a heart attack. Adenosine may protect heart tissue and improve outcomes.
Karachi, SindhAges 18–80 - NCT07556887Recruiting
Using IMPROVE to Choose Carotid Artery Treatment After Stroke
This study tests whether a new tool called IMPROVE helps doctors decide if you need surgery or a stent to clear a narrowed carotid artery (a major neck blood vessel) after a recent stroke or mini-stroke. The goal is to better predict which patients will benefit most from this treatment.
Arnhem, GelderlandAges 18 years+ - NCT07610538Recruiting
Low-dose IL-2 study after heart bypass surgery
This study tests whether a low dose of a natural immune-boosting protein (IL-2) given after heart bypass surgery can help reduce heart damage. The treatment aims to activate special immune cells that protect heart tissue.
Cambridge, CambridgeshireAges 18 years+ - NCT07620119Recruiting
AI-assisted heart attack diagnosis in patients with LBBB
This study tests whether artificial intelligence can help doctors more accurately diagnose heart attacks in patients who have a specific heart rhythm pattern called Left Bundle Branch Block (LBBB). The goal is to improve emergency care by reducing delays in identifying who needs urgent treatment.
Konya, KaratayAges 18 years+ - NCT07655479Recruiting
Switching to a stronger heart pump after heart attack
This trial tests whether switching to a more powerful heart pump (Impella 5.5) within 24 hours of a heart attack helps people whose hearts are still struggling despite a standard pump. It may be an option for patients who had a heart attack, received an Impella CP pump, but still need strong medication to keep blood flowing.
CologneAges 18–77 - NCT06763549Enrolling by invitation
AI-powered wearable patch for heart and lung monitoring
This study tests an AI-powered wearable patch (the COR ECG) to see if it can better track heart and lung health. It may help doctors find problems earlier without needing bulky equipment.
Melbourne, FloridaAges 18 years+ - NCT04617639Enrolling by invitation
Exercise program after a heart attack in Norway
This trial tests whether a structured physical exercise plan can help people recover and stay healthier after a heart attack. It is designed for people who can safely be active and are not already doing as much exercise as the program requires.
TrondheimAges 18–79 - NCT07772570Recruiting
Studying blood markers in coronary artery disease
This study collects blood samples and images from patients with heart muscle damage or those undergoing coronary angiography. The goal is to find new biomarkers that could improve diagnosis and treatment of coronary artery disease.
OxfordAges 18–90 - NCT07689591Recruiting
Non-invasive blood flow boost for heart attack patients
This trial tests a non-invasive method to improve blood flow in the arm during a heart attack. It may help reduce heart muscle damage before the standard artery-opening procedure.
Elâzığ, ElaziğAges 18–80 - NCT07268391Recruiting
Advanced scans to understand heart healing after heart attack
This study uses advanced CT scans and blood tests to look at how the heart is damaged and recovers after a first heart attack. It may help doctors find better ways to treat heart attacks in the future.
MadridAges 18 years+ - NCT06548204RecruitingPhase 2
Antihistamine after a heart attack
This trial tests whether taking an antihistamine medicine called fexofenadine hydrochloride can help people recover better after a heart attack. It is a randomized study, so some participants will receive the medicine and others will receive a placebo (a pill with no active ingredients).
Hangzhou, ZhejiangAges 18 years+ - NCT07142265Recruiting
Early inclisiran after heart attack trial
This trial tests if giving inclisiran early after a heart attack can lower cholesterol more effectively. It is for people who have had a recent heart attack and still have high LDL cholesterol despite taking statins.
CheboksaryAges 18–100 - NCT07381803RecruitingPhase 3
Fexofenadine for heart attack recovery
This trial tests if the allergy medicine fexofenadine can improve recovery after a heart attack. You may qualify if you had a specific type of heart attack (STEMI) within the last week.
Hangzhou, ZhejiangAges 18 years+ - NCT06404242Recruiting
Plaque features predict repeat stroke after middle cerebral artery blockage
This study looks at people who recently had a stroke caused by hardening of the arteries in the middle cerebral artery, a major blood vessel in the brain. The researchers use special MRI scans to see if the plaque (the fatty buildup) can predict whether another stroke might happen.
Ho Chi Minh City, Ho Chi Minh CityAges 45–100 - NCT04731155RecruitingPhase 4
Test early PCSK9 medicine to prevent heart problems after a heart attack
This trial studies whether starting a cholesterol-lowering medicine called a PCSK9 inhibitor early after a heart attack can improve heart health and outcomes. It focuses on people who had a recent heart-artery procedure to fix the blockage in the left anterior descending (LAD) artery.
Shanghai, Shanghai MunicipalityAges 18–80 - NCT05073419Recruiting
Test for heart rhythm issues after a heart attack
This trial checks how well a small heart monitor device can detect abnormal heart rhythms after a recent heart attack. It may help doctors catch rhythm problems early, which could improve follow-up care after discharge.
Pittsburgh, PennsylvaniaAges 18 years+ - NCT04755387RecruitingPhase 4
Lower-dose blood thinner after heart attack stent
This trial looks at whether switching to a “lower-intensity” blood thinner plan after a heart attack and stent is safer and still works well. It may help reduce bleeding risk compared with a stronger approach, while protecting the stent from clots.
BusanAges 19–80 - NCT04619355Recruiting
People who had a special heart scan during stent placement
This study follows people who already had a stent put in (PCI) using a special imaging test (NIRS-IVUS) to look at heart outcomes over time. If you agreed and can attend follow-up visits, this registry may help doctors better understand how this imaging-guided approach performs.
SeoulAges 19 years+ - NCT04449523Recruiting
Check for hidden heart rhythm problems after silent brain strokes
This study looks at how often “silent” atrial fibrillation—an irregular heart rhythm that can be symptom-free—happens in people who have silent brain stroke spots on MRI. If it finds a link, it may help identify which patients might benefit from closer heart monitoring or prevention steps.
GrazAges 50 years+ - NCT06964685Recruiting
Impella heart pump in heart attack with shock
This study looks at how well the Impella CP heart pump works for people who have a severe heart attack that causes their heart to pump too weakly to keep blood flowing to their body. It's a registry that follows your care to improve best practices.
Jonesboro, ArkansasAges 18 years+ - NCT07626060Recruiting
AI Tools for Chest Pain Risk Assessment
This study tests whether artificial intelligence (AI) programs can accurately calculate a chest pain risk score to help doctors decide who needs urgent heart tests. You'll be monitored for 30 days to see if the AI's predictions were correct.
Istanbul, IstanbulAges 18 years+
Hear when a new Infarction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for infarction?
- Yes. Clin2 currently lists 395 recruiting infarction studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a infarction trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a infarction trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.